Factors influencing insulin sensitivity in patients with mild primary hyperparathyroidism before and after parathyroidectomy. 2012

Erik G Almqvist, and Anne-Greth Bondeson, and Lennart Bondeson, and Dan Mellström, and Johan Svensson
Department of Medicine, Central Hospital, Skövde, Sweden. erik.almqvist@vgregion.se

OBJECTIVE Primary hyperparathyroidism (PHPT) is associated with cardiovascular disease. The aims of this study were to investigate lipid and glucose metabolism in mild PHPT, and to identify whether insulin sensitivity correlates with circulating levels of adiponectin, SHBG, and osteocalcin before and after parathyroidectomy (PTX). METHODS Forty-five patients with PHPT were examined before and 1 year after PTX. Circulating levels of triglycerides, total cholesterol, HDL-cholesterol, insulin, glucose, adiponectin, SHBG, osteocalcin, and erythropoietin were measured. RESULTS At baseline, the mean serum levels of total cholesterol, LDL-cholesterol and triglycerides were above the upper reference limit or in the upper normal range, and insulin sensitivity was reduced as assessed using the HOMA index. One year after parathyroidectomy, serum lipids as well as HOMA index and erythropoietin were unchanged while adiponectin had increased (p < 0.05), and SHBG and osteocalcin had decreased (p < 0.05 and p < 0.0001, respectively). HOMA index correlated negatively with circulating levels of adiponectin, SHBG and osteocalcin. In multiple regression analysis SHBG was the most important predictor of insulin sensitivity, both pre- and postoperatively. CONCLUSIONS Untreated mild PHPT is associated with a moderate derangement of lipid and glucose metabolism. As previously shown in population-based cohorts, insulin sensitivity is positively associated with circulating concentrations of adiponectin, SHBG and osteocalcin. One year after PTX, the mean level of adiponectin was increased, but the levels of SHBG and osteocalcin had decreased and the levels of serum lipids and the insulin sensitivity remained unchanged as compared with baseline.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007333 Insulin Resistance Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS. Insulin Sensitivity,Resistance, Insulin,Sensitivity, Insulin
D008055 Lipids A generic term for fats and lipoids, the alcohol-ether-soluble constituents of protoplasm, which are insoluble in water. They comprise the fats, fatty oils, essential oils, waxes, phospholipids, glycolipids, sulfolipids, aminolipids, chromolipids (lipochromes), and fatty acids. (Grant & Hackh's Chemical Dictionary, 5th ed) Lipid
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D004921 Erythropoietin Glycoprotein hormone, secreted chiefly by the KIDNEY in the adult and the LIVER in the FETUS, that acts on erythroid stem cells of the BONE MARROW to stimulate proliferation and differentiation.
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

Erik G Almqvist, and Anne-Greth Bondeson, and Lennart Bondeson, and Dan Mellström, and Johan Svensson
June 1991, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
Erik G Almqvist, and Anne-Greth Bondeson, and Lennart Bondeson, and Dan Mellström, and Johan Svensson
May 1983, MMW, Munchener medizinische Wochenschrift,
Erik G Almqvist, and Anne-Greth Bondeson, and Lennart Bondeson, and Dan Mellström, and Johan Svensson
October 2021, Endocrinology, diabetes & metabolism,
Erik G Almqvist, and Anne-Greth Bondeson, and Lennart Bondeson, and Dan Mellström, and Johan Svensson
May 2010, Endocrine research,
Erik G Almqvist, and Anne-Greth Bondeson, and Lennart Bondeson, and Dan Mellström, and Johan Svensson
December 1985, Experimental and clinical endocrinology,
Erik G Almqvist, and Anne-Greth Bondeson, and Lennart Bondeson, and Dan Mellström, and Johan Svensson
August 1977, Clinica chimica acta; international journal of clinical chemistry,
Erik G Almqvist, and Anne-Greth Bondeson, and Lennart Bondeson, and Dan Mellström, and Johan Svensson
July 2014, Urology,
Erik G Almqvist, and Anne-Greth Bondeson, and Lennart Bondeson, and Dan Mellström, and Johan Svensson
November 2020, The Journal of surgical research,
Erik G Almqvist, and Anne-Greth Bondeson, and Lennart Bondeson, and Dan Mellström, and Johan Svensson
December 2015, Clinical endocrinology,
Erik G Almqvist, and Anne-Greth Bondeson, and Lennart Bondeson, and Dan Mellström, and Johan Svensson
November 2020, Endocrine,
Copied contents to your clipboard!